Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
- Creator: Kalincik, Tomas , Brown, J. William L. , McGuigan, Christopher , Jokubaitis, Vilija , Spelman, Tim , Horakova, Dana , Havrdova, Eva , Trojano, Maria , Izquierdo, Guillermo , Lugaresi, Alessandra , Prat, Alexandre , Girard, Marc , Robertson, Neil , Lechner-Scott, Jeannette , Willis, Mark , Scolding, Neil , Rice, Claire M. , Wilkins, Alastair , Pearson, Owen , Ziemssen, Tjalf , Hutchinson, Michael
- Resource Type: journal article
- Date: 2017
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season
- Creator: Parnell, Grant P. , Gatt, Prudence N. , Liddle, Christopher , Slee, Mark , Vucic, Steve , Stewart, Graeme J. , Booth, David R. , McKay, Fiona C. , Schibeci, Stephen , Krupa, Malgorzata , Powell, Joseph E. , Visscher, Peter M. , Montgomery, Grant W. , Lechner-Scott, Jeannette , Broadley, Simon
- Resource Type: journal article
- Date: 2014